background: One in six couples suffer from infertility problems requiring in vitro fertilization therapy; however, the average birth rates in the past decade per IVF -embryo transfer cycle have remained static at around 25%. Although implantation failure is considered a major cause of infertility in otherwise healthy women, inadequate uterine receptivity is considered to be responsible for only two-thirds of implantation failures and problems with the embryo itself are responsible for the other third, such that only 30% of oocytes that are contacted by sperm result in successful human term pregnancies. Due to technical and ethical considerations, most research into the factors affecting the success of embryo implantation has been performed in mice, but this may be less than ideal.
Introduction
Following fertilization and rapid cell division, the conceptus in successful pregnancies needs a controlled supply of oxygen and metabolic substrates in order to grow and develop. Initially, it obtains these from uterine secretions, primarily the endometrial glands with some material produced by the endometrial stroma that transforms into the decidua. These organic molecules and ions are supplied through specific transport mechanisms, while the exchange of oxygen and carbon dioxide is diffusional. There is however a limit to the size that a free-living conceptus can reach before these supplies become inadequate to maintain survival. At this critical point, a suitable mechanism for supplying these nutrients must be established for implantation to be successful.
The exact point in the reproductive cycle at which this occurs varies from mammal to mammal, but one common theme is that the implanted conceptus needs to develop its own blood supply through the generation of a local vascular system. It is through this vasculogenesis that essential metabolites at the extra-embryonic surface are exchanged and subsequently distributed throughout the conceptus' own developing tissues. Simultaneously, waste products are returned to the maternal system and excreted by the mother. To do this, mammals have developed a unique organ that regulates this process, called the placenta. The main functional cell in the early placenta, the trophoblast, develops as the conceptus reaches the blastocyst stage.
It is this trophoblastic tissue that implants into the endometrium and facilitates the exchange of nutrients and waste. Implantation can only occur successfully during the 'window of implantation', a critical time period when both the uterine environment is receptive to blastocyst implantation and the blastocyst is in an 'active' state.
In this review, we set out to explore what is already known about embryo implantation, with a specific focus on the similarities and differences in this process in human and mice. To achieve this, selected relevant literature, pertaining to both rodent and human reproductive physiology related to implantation, were considered for inclusion.
Methods
We performed a search of the English medical literature using PubMed between 1975 and 2012 for relevant articles detailing the similarities and differences between rodent and human reproductive physiology surrounding implantation. Search terms and combinations included ovulation, fertilization, implantation, immune response to implantation, placentation, endocannabinoids and implantation. Identified articles were then reviewed in detailed for relevance to the review. We included only primary papers and review articles (and primary sources within those) where there was a clear indication for a particular ligand or cell being involved in the implantation process or placentation in the mouse or woman.
The primary search was performed by S.E.M. and A.H.T., but all the authors subsequently checked the appropriateness of the included articles in the review.
The normal process of implantation
There are three stages to implantation: apposition, adhesion and penetration. During apposition, the blastocyst comes into close proximity with the luminal surfaces of the endometrium and a dialogue between the polarized trophoblast and these luminal epithelial cells is initiated. When the blastocyst comes into this close contact, it interacts with bleb-like protrusions that have developed on the apical surface of the endometrium (Usadi et al., 2003) . These blebs, known as pinopodes, appear to be progesterone-dependent as their development is linked to the plasma mid-luteal increase in progesterone levels (Stavreus-Evers et al., 2001; Achache and Revel, 2006) . In humans, endometrial pinopode development is also associated with the increased expression of leukaemia inhibitory factor (LIF) and its receptor (Aghajanova et al., 2003) , as well as the integrin aV3b (Lessey et al., 1992) , and is dependent on the activation of the homeobox transcription factor, HOXA-10 ( Bagot et al., 2001) . While this has also been shown in the rat endometrium, murine studies have shown that pinopodes also develop in LIF and HOXA10 null mice (Quinn and Claire, 2007) . Although the exact role of pinopodes remains unknown, these may indeed be the preferred sites for embryo -endometrial interactions and the attachment of the blastocyst has been shown to occur above endometrial pinopodes that have undergone cycle-dependent morphological changes (Achache and Revel, 2006) . These changes are only present for a maximum of 2 days of the menstrual cycle (Rashid et al., 2011) , usually 2-4 days after ovulation in women, and at 24 -36 h in mice. As apposition completes, microvilli on both trophoblast and endometrial surfaces interdigitate and the pinopodes are withdrawn.
Following apposition, the blastocyst needs to adhere tightly to the endometrium; otherwise, it will detach and 'float' around the uterus. During this period when the microvilli disappear, glycoproteins (especially the integrins and cadherins) are produced, leading to increased cell-to-cell contact over a large surface area. The role of these glycoproteins is to firmly attach the blastocyst to the endometrial epithelial cell surface . Integrins are a family of transmembranous glycoproteins composed of a non-convalently linked a and b subunit (Lessey et al., 1992) . Both luminal and glandular epithelium are known to express a wide variety of integrins. While most of these are expressed throughout the entire menstrual cycle, the expression of some is more cycle-specific (Lessey et al., 2000) . Integrins whose expression is increased in the mid-luteal phase are thought to be involved in coordinating the 'window of implantation' (Lessey et al., 1992) . Of these, aV3b integrin has been identified as a potential receptor for embryonic attachment and has been linked to endometrial pinopode development (Lessey et al., 1992; Lessey, 2003) . Cadherins are a different class of glycoproteins responsible for a calcium-dependent cell-to-cell adhesion through the production of gap junctions, adherens junctions and other less defined cell-to-cell contacts. They are divided into three subclasses, E, P and N. With regard to implantation, E-cadherin is the most studied subclass and it is its binding through other adherens junction proteins, such as b catenin and plakoglobin, that keeps the two cells close together (Larue et al., 1994; Collins and Fleming, 1995; Aberle et al., 1996) .
The final stage of implantation, penetration, involves contraction of microfilaments in the trophoblast, which allows the blastocyst to invade between endometrial cells. Concurrently, a newly specialized cell generated from the underlying trophoblast layer, the syncytiotrophoblast, forms and the synthesis of syncytiotrophoblast-specific proteins (including hCG) begins. This promotes two main events: the establishment and maintenance of the corpus luteum (in the ovary) and the development of decidual cells, which 'pump' out high levels of insulin-like growth factor binding protein 1 and prolactin to support the ongoing pregnancy.
To ensure that implantation occurs before the nutrients obtained from the uterine secretions become inadequate, these steps tend to happen when the blastocyst is relatively small, and initially only a few trophoblastic cells are involved in making contact with the maternal epithelium. However, within a few hours of this initial contact, the area of stromal tissue underlying the blastocyst becomes increasingly vascular (Matsumoto et al., 2002) , pointing to the release of pro-angiogenesis factors by the trophoblast. Concomitantly, there is associated oedema and localized changes in the intercellular matrix, with progressive sprouting and in-growth of capillaries (vasculogenesis). These changes are known as the 'primary decidualization reaction', a process that is particularly marked in primates and rodents. As the trophoblastic tissue invades further into the uterine glandular tissue and decidual tissue, the adjacent cells are destroyed, primarily through apoptosis. This results in the release of primary metabolic substrates, which are taken up by the growing conceptus (acting as a 'yolk reservoir'). The goal of this trophoblastic invasion is to find the uterine spiral arteries and plug them to prevent the inflow of maternal blood into the developing implantation site, because too much oxygen at this stage could damage the developing embryo.
Placentation
When considering viviparity (the bearing of live young) in vertebrates, including fish, reptiles and mammals, the placenta can be considered to be the most evolved step. Compared with a less evolved form of viviparity, known as 'ovoviviparity' (where the mother holds yolky eggs in her body until they hatch), the placenta allows the developing fetus to extract nutrients from the mother, while still providing protection from both predators and cold, inhospitable environments (Moffett and Loke, 2006) .
In the human and mouse, the formation of the placenta begins when the embryo reaches the 'blastocyst stage' where there is organization of the cells into an outer layer (which will form the trophoblast), a blastocoelic fluid and an inner cell mass (ICM). The trophoblast forms outer (syncytiotrophoblast) and inner (cytotrophoblast) cellular layers, while the ICM goes on to form the embryonic disc (which will eventually give rise to the definitive structures of the fetus). An amniotic cavity forms between the cytotrophoblast and the epithelial layers of the embryonic disc.
In all species, the trophoblast cells form the outermost layer of fetal cells, and these overlie an inner core of mesenchyme and fetal capillaries. However, there are noticeable differences between species when considering the extent of invasion of trophoblast cells into the uterus, which can range from no invasion (as seen in horses and whales) to very extensive invasion (as seen in humans, rodents and rabbits).
The least invasive form is epitheliochorial placentation (often referred to as synepitheliochorial or syndesmochorial placentation when associated with fusion of binucleate cells in ruminant placentae), where trophoblast cells are in direct apposition with the uterine surface epithelial cells but do not invade beyond this point. A slightly more invasive form, the endotheliochorial placentation, is where the uterine epithelium is breached and results in trophoblast cells coming into direct contact with endothelial cells of maternal uterine blood vessels. The most invasive form, haemochorial placentation, is where trophoblast cells infiltrate maternal uterine blood vessels causing them to rupture and release of blood into the intervillous space, which result in the syncytiotrophoblast being bathed in blood (these are depicted in Fig. 1 ).
With such diversity in placentation, it is follows that the mechanisms for increasing blood flow to the feto-placental unit also differ. For example, in epitheliochorial placentation, this is achieved through the angiogenic expansion of the vascular bed size in the uterus, whereas in the haemochorial placentation, a lowering of resistance caused by the modification of the walls of arteries results in an increased low-pressure blood flow system.
While both humans and mice have haemochorial placentae, one fundamental difference between human and rodents is the depth to which the epithelium is invaded by the blastocyst. Human (as well as chimpanzee and guinea pig) placentae implant interstitially; that is to say, the conceptus deeply invades the stroma, while the surface epithelium becomes Mechanisms of implantation restored over it. When comparing the depth of placental invasion for all mammals with interstitial implantation, human placentae are found to be particularly invasive. In contrast, rodent, cat, dog and the rhesus monkey conceptuses implant eccentrically, in that the stroma is only partially invaded and the conceptus continues to project to varying degrees into the uterine lumen.
The overall effect though is that haemochorial placentae provide the fetus with direct access to maternal blood, and therefore easy access to nutrients. However, a disadvantage of such a close interaction (with mother and fetus no longer separated by an intact layer of epithelial cells) is that of exposure of the trophoblast cells to potential allogenic immune responses by the mother.
Immune responses to implantation
It therefore follows that as well as allowing the exchange of gases, nutrients and waste products, another important function of the placenta is the regulation of the maternal immune response thereby ensuring tolerance of the fetal semi-allograft. Breaching of the endometrial basement membrane results in trophoblast cells coming into direct contact with decidual cells, along with other components of stromal tissue, such as fibroblasts, macrophages and T-cells. Because of this, trophoblast cells are presumed to be key in preventing the rejection of the fetal semi-allograft. Trophoblast cells in primates encounter the maternal immune system in two ways: interactions (i) between villous trophoblast cells and maternal blood and (ii) between the extravillous trophoblast (EVT) cells and the uterine tissue. The ability to evade the maternal immune response is critical for assisted reproductive techniques, which use donated embryos; in these cases, the fetus is a complete allograft, with no maternal genes whatsoever, yet the pregnancy is still able to establish without an increased rate of miscarriage (Saito et al., 2007) .
Major histocompatibility complex
The important components of the immune system in this regard are the major histocompatibility complexes (MHC) class I and II. These are responsible for presenting peptide antigens to antigen receptors on surveillance immune cells. MHC class I proteins are expressed on all nucleated somatic cells and can be divided into two broad groups: classical and nonclassical. Classical MHC class I genes are highly polymorphic and encode proteins that are expressed in most somatic cells. They present peptides from intracellular pathogens ('non-self'), along with 'self' cells, to T-cell receptors (TCRs) on T-lymphocytes. Non-classical class I genes have diverse functions, and one of the important ones is acting as ligands for inhibitory leucocyte receptors, some of which are encoded within the natural killer complex. In contrast, MHC class II proteins are only expressed on professional antigen-presenting cells (APCs) (e.g. dendritic cells, macrophages and B-cells) (Parham et al., 2012) .
Classical MHC class I and II genes are the most polymorphic genes in the human genome. This high degree of variation is thought to have arisen through pathogen-driven selection and thus provides increased protection from various pathogens. The different number of polymorphisms in the MHC class I for human placenta is shown in Table I .
In humans, the MHC system is also known as the human leucocyte antigen (HLA) system (Parham et al., 2012) . Focusing on its involvement in implantation, this group of trophoblast HLA class I expression is unique (Chaouat, 2001; Moffett and Loke, 2006) . There is no expression of the highly polymorphic HLA-A or HLA-B molecules, which function mainly as T-cell ligands. There is, however, expression of oligomorphic nonclassical HLA class I molecules, HLA-G and HLA-E (Saito et al., 2007; Parham et al., 2012) . The only polymorphic HLA molecule expressed is HLA-C, and this is predominantly expressed in EVT. This lack of polymorphism is thought to offer the embryo some protection from the maternal immune system.
Cytokines
For an immune response mediated by T-cell activation to occur, several interactions between the antigen and the TCR have to take place in a coordinated manner. First, the antigen must be presented to the T-cell as a peptide fragment within the groove of the MHC molecule. This is necessary because the TCR will only recognize the combined shape of the foreign antigen together with self-MHC; free antigen will have no effect. For some time, it was believed that CD8 + (cytotoxic) T-cells recognized antigens with class I MHC and CD4 + (helper) T-cells were more limited and could only be stimulated by cells that bear MHC class II (Parham et al., 2012) . The class I MHC molecule is present on all nucleated somatic cells (Davies, 2007) and so nearly all cells can present to cytotoxic T-cells. In contrast, class II MHC molecule expression is limited to APCs (Parham et al., 2012) . However, it has been shown that HLA-G antigens are able to trigger CD4 + as well as CD8 + T-cells (van der Meer et al., 2007) .
Triggered CD4
+ T-cells, also known as T-helper cells, are involved in orchestrating the immune response (Piccinni, 2010) . They cannot directly destroy their target, but recognize specific foreign antigen and proceed to activate other parts of the system which can eradicate it. T-helper cells have been categorized into three major functional subpopulations based on their pattern of cytokine production: T-helper 1 (Th1) and T-helper 2 (Th2) and the more recently discovered T-helper 17 (Th17). Table II summarizes the actions of the three classes of T-helper cells, namely the cytokines produced along with the specific immune cells that are activated and the responses initiated. Chaouat et al. (2007) concluded from a review of murine studies that while Th1-type cytokines (pro-inflammatory) appear to be important determinants of the attachment and adhesion stages of implantation, and that an excess of preimplantation Th1 cytokines might induce early miscarriage. Th1 cytokines include IFNg and tumour growth factor (TGF)-b, both of which are known to play important roles in enhancing implantation (Lee et al., 2011) . IFNg has been shown to stimulate changes to the vasculature of the endometrium, that in turn, improves 
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implantation success, while TGF-bs are well known to be immunosuppressive and also to act on both LIF (see below) and interleukin-6 (IL-6) pathways. IL-6 (along with IL-1) exerts a strong stimulatory effect on endometrial expression of corticotrophin-releasing factor (CRF), which is known to induce decidualization of endometrial stromal cells (Ferrari et al., 1995) . Female rats were shown to have a marked reduction in implantation and live embryos following treatment with antalarmin, a CRF receptor antagonist (Makrigiannakis et al., 2001) . While able to demonstrate the importance of the pro-inflammatory Th1-type cytokines, Chaouat (2001) did not demonstrate a mandatory requirement for Th2-type cytokines (anti-inflammatory) in the implantation process. Further supporting the notion that implantation is a pro-inflammatory condition, Zhou et al. (2008) and Barash et al. (2003) have both demonstrated that wounding the endometrium with a biopsy catheter improves embryo implantation (Revel, 2009) . Th17 may play a role in inflammation, but its role in implantation is yet to be fully defined (Nakashima et al., 2010a, b; Saito et al., 2010; Lee et al., 2011) .
Conversely, for stages of pregnancy after implantation, Th1 cytokines are thought to compromise pregnancy success, whereas Th2 cytokines promote allograft tolerance (by inhibiting Th1 responses) and therefore may improve fetal survival Piccinni, 2010; Lee et al., 2011) . As with many of the components involved in implantation, there are no 'good' or 'bad' cytokines, but instead it is the balance of production in conjunction with the timing of production that affect all stages of pregnancy.
Natural killer cells
NK cells are activated by cytokines produced by Th1 cells. These cells which are part of the lymphoid lineage, and just like T-and B-lymphocytes, can be divided into several subpopulations. Uterine NK (uNK) cells are different from those in the systemic circulation both phenotypically and functionally (King et al., 1998; Lee et al., 2011) . uNK cells are the main immune maternal cells present in the decidualized endometrium prior to and during the establishment of the placenta in species with invasive haemochorial placentation (Moffett and Loke, 2006) ; it has been estimated that up to 60-80% of the peri-implantation uterus, stroma in mice and humans comprises uNK cells, which is more lymphocytes than are present in some lymph nodes (King et al., 1998; Chaouat et al., 2007) .
NK cells display killer-cell immunoglobulin-like receptors (KIRs) that become activated continuously by the recognition of endogenous self-MHC, and this activation inhibits lysis. The lack of MHC (i.e. in a 'non-self' cell) deactivates KIR and thus activates NK cells to destroy the MHC-negative cell (Parham et al., 2012) . Although very few cells (trophoblast and thymus) express HLA-G, all NK cells express the HLA-G binding KIR and KIR2DL4 (Moffett and Loke, 2006) . This helps prevent human fetal rejection by NK cells as the trophoblast becomes less sensitive to NK-medicated lysis (although 100% inhibition of NK-medicated lysis has not been observed) (Chaouat, 2001) .
uNK cells are known to secrete a variety of angiogenic factors such angiopoietin 2 and vascular endothelial growth factor (VEGF), which in turn stimulate the thickening of the vascular walls to ensure successful implantation (Lee et al., 2011) . While mice lacking uNK cells are fertile, they display inadequate uterine vascular remodelling during pregnancy, poor decidualization and low fetal weight, highlighting the importance of uNK cells in implantation (Colucci et al., 2011) . These findings have been investigated further, reaching the conclusion that in NK+/+ mice, IFNg activates NK cells which in turn stimulates vascular changes as detailed above, whereas in NK2/2 mice, IFNg stimulates the vascular changes directly.
The presence of uNK cells in the media of the arteries in mice suggests a possible direct physiological role in the regulation of blood pressure and flow within the placenta. In the mouse, uNK cells may modify blood flow indirectly by their effects on trophoblast cell behaviour. Whether uNK cells in mice and humans have the same role or use the same molecular mechanisms is uncertain (Moffett and Loke, 2006) .
Key ligands in implantation
Successful implantation results from a complex interaction of numerous active ligands with their receptors. Studies have identified some of these as vital for a successful implantation, whereas others are merely beneficial to the process.
In the context of ligands involved in implantation, the roles of the primary gonadal steroid hormones (estradiol-17b and progesterone) are best understood. As already discussed, both the endometrium and the blastocyst are involved in the 'window of implantation'. In humans, this is considered to be 5-9 days after ovulation, i.e. in the middle of the luteal phase of the normal menstrual cycle (Days 20 -24) (Wilcox et al., 1999) and spans a 3-day period, whereas in mice, it lasts for 24 h and occurs on Day 4 of their cycle.
For the human uterus to achieve a 'receptive state', it first requires a pre-ovulatory increase in estrogen secretion (Norwitz et al., 2001) , primarily in the form of 17b-estradiol (E 2 ), to stimulate proliferation and differentiation of uterine epithelial cells. Next, it needs a continued production of progesterone (by the corpus luteum) to enable further proliferation and differentiation of the E 2 primed stromal cells into decidual cells (Salamonsen et al., 2003) . High levels of progesterone also inhibit GnRH secretion by the hypothalamus, resulting in a reduction in LH and FSH (and thus preventing further ovulation). With successful implantation, hCG secreted by the embryo ensures the corpus luteum continues to secrete progesterone until the placenta is able to support the pregnancy itself. The uterus of the mouse achieves a receptive state in much the same way as the human uterus, by the coordinated effects of estrogen and progesterone (Song et al., 2000) . In contrast, the ovulatory cycle of small rodents, such as mice and rats, is considered to be an 'incomplete cycle' in that ovulation occurs every 4-5 days (Caligioni, 2009 ), but the corpus luteum formed is not fully functional, and its inhibitory effect on the secretion of GnRH (and thus LH and FSH) only occurs following mechanical stimulation of the cervix (Milligan, 1975; Smith et al., 1975) .
When considering the uterine environment, it is worth mentioning that humans have a menstrual cycle and the mouse has an oestrous cycle. Both are under the influence of the hypothalamic -pituitary axis, but while humans shed the endometrial lining at the end of each cycle, mice reabsorb the endometrium if conception does not occur during that cycle. Interestingly, decidualization occurs in humans in the absence of an embryo (although the extent of the reaction is enhanced by implantation), whereas the presence of an embryo is necessary for the same reaction in rodents (Salamonsen et al., 2003) . This suggests that slightly different mechanisms are in place during the period of implantation in mice and women. While progesterone has been shown to be necessary for decidualization, Das et al. (2009) demonstrated that estrogen is not essential for this process, but it is critical for uterine angiogenesis during this time.
The receptive uterus can only accept an 'active' blastocyst. Using a mouse model, Paria et al. (1993) demonstrated that it is a metabolite of E 2 that causes the blastocyst to become activated for implantation. This estrogen, 4-OH-E 2 , is formed by aromatic hydroxylation of phenolic estrogen at C-4 and activates dormant blastocysts via generation of prostaglandins (PGs) (with the induction of uterine COX-2 at the sites of blastocyst apposition).
It is known that elimination of preimplantation E 2 secretion results in implantation failure (Das et al., 2009 ), but in these situations, the blastocyst can sometimes remain dormant in the quiescent uterine lumen. As well as being demonstrated in laboratory conditions (Wang et al., 2006a, b) , it can also be observed in nature. Suppression of endogenous estrogens in rats that are suckling the previous litter prevents further pregnancies, a process known as facultative delayed implantation. In many species (e.g. badger, elephant seal, stoat and brown bear), an obligatory delayed implantation is necessary to allow the animals to mate in the summer when the adults are well fed and in their prime, but for the pregnancy to be delayed to allow parturition to occur in the following summer when there will be plentiful food supplies available. Paria et al. (1993) in highlighting the interplay between the endometrium and blastocyst demonstrated that the 'window of implantation' in the mouse uterus remains open for less than a day when exposed to 'active' blastocysts, and even for a shorter time period when exposed to 'dormant' blastocysts. Even after activating dormant blastocysts with E 2 , the 'window of implantation' was shorter when compared with blastocysts that had remained active throughout the implantation process. They also demonstrated that unless the endometrium was receptive (that is to say, it had been primed with progesterone and then activated with E 2 ), active blastocysts failed to implant.
Progesterone plays an equally important role in successful implantation, and progesterone-receptor antagonists readily induce abortion, if given before 7 weeks of gestation (Peyron et al., 1993) . Early luteal phase administration of mifepristone (an antiprogestin) induces desynchronization of endometrial development and repression of glandular secretory differentiation and vascular maturation (Marions and Danielsson, 1999) . In addition, pinopode development is closely linked to progesterone concentrations (Stavreus-Evers et al., 2001) .
While the importance of estradiol-17b and progesterone in implantation are best understood, they are far from the sole components influencing the success of this process. It is well documented that many components secreted by both the embryo and the endometrium play an important part in implantation, and these interactions between the embryo and endometrium start well before the embryo attaches to the endometrial epithelial surface. For example, it is known that the embryo secretes frucosylated oligosaccharides, such as ghrelin and LIF, and the endometrium expresses receptors for these ligands. Similarly, the endometrium secretes Heparin-binding EGF-like growth factor (HB-EGF), insulin-like growth factor and LIF which interact with receptors expressed by the embryo (Aghajanova, 2010) .
The medium in which preimplantation embryos have been cultured has been shown to contain a variety of other active substances, including TGF a and b, platelet-derived growth factor, colony-stimulating factor 1, IL-1, IL-6, PG E 2 and platelet-activating factor (Stewart and Cullinan, 1997) . After decades of investigating different factors influencing implantation, some components have been identified as being crucial for its success. There are too many to discuss in this review, but four appear to be the most important: LIF, HOXA10, cyclooxygenase-2 (COX-2) and anandamide (AEA). LIF, COX-2 and HOXA-10 are essential to the implantation process and null mutation of these genes results in defective implantation. Conversely, high levels of the endocannabinoid, AEA, have been shown to have adverse effects on reproductive function in mice and women (Paria et al., , 2001 Maccarrone et al., 2002a, b; Maccarrone, 2009 ) including retarded embryo development, fetal loss and pregnancy failure.
Leukaemia inhibitory factor
LIF is a pleiotropic cytokine that has been shown to regulate various cellular functions including proliferation and differentiation, and is a member of the IL-6 family (Diedrich et al., 2007; Markert et al., 2011) . The IL-6 family members share a common receptor for signal transduction, resulting in considerable overlap among the cytokines (Song et al., 2000) and low levels of IL-6 have been associated with recurrent miscarriages . Both the human embryo and the endometrium secrete LIF (Cameron et al., 1997; van der Gaast et al., 2009) , and both possess LIF receptors (Aghajanova, 2010) , suggesting that interactions between the embryo and endometrium start before the embryo attaches itself to the endometrial epithelial surface.
LIF also plays a role in both the adhesive and invasive phases of implantation due to its anchoring effect on the trophoblast and regulation of trophoblast differentiation. Pinopodes have been shown to release LIFcontaining vesicles into the uterine lumen (Kabir-Salmani et al., 2005) and this then modulates trophoblast invasiveness, and affects immune tolerance by controlling human HLA-G expression of invasive cytotrophoblast cells during implantation (Aghajanova, 2010) .
LIF was the first cytokine to be demonstrated to be vital for implantation in mice, as LIF knockout mice (even when impregnated with LIF +/+ embryos) displayed total implantation failure, a phenomenon that could be resolved with continuous injection of recombinant LIF (Stewart et al., 1992) . However, there are LIF 'over producers' in sterile women, hence not all infertility is due to LIF deficiency and 'too much' LIF in the luminal fluid is a predictor of poor IVF -embryo transfer (ET) outcome (Ledee-Bataille et al., 2002) . LIF has also been shown to modulate trophoblast invasiveness and affect immune tolerance by controlling HLA-G expression of invasive cytotrophoblast cells during implantation (van der Gaast et al., 2009).
LIF production is boosted by progesterone and endometrial expression of LIF is decreased following treatment with the antiprogestin mifepristone (Cameron et al., 1997; Marions and Danielsson, 1999) . Treatment with mifepristone during the luteal phase of the menstrual cycle has also been shown to affect levels of PG F 2a , PG E2 and COX in the human endometrium (Gemzell-Danielsson and Hamberg, 1994; Nayak et al., 1998) .
Cyclooxygenase-2
COX is the rate-limiting enzyme involved in the conversion of arachidonic acid to PGs, and is found in three isoforms COX-1, COX-2 and the more recently identified COX-3 (Chakraborty et al., 1996; Chandrasekharan et al., 2002) . COX-1 and -2 are encoded by two separate genes and exhibit distinct cell-specific expression, regulation and subcellular localization, yet share similar structural and kinetic properties (Lim et al., 1997) , whereas COX-3 is encoded by the same gene as COX-1 (Chandrasekharan et al., 2002). COX-1 is a constitutive enzyme located in the endoplasmic reticulum of most mammalian cells (Chakraborty et al., 1996) and PGs synthesized here exit the cell via G-protein-coupled cell surface receptors. In contrast, COX-2 is an inducible enzyme (Kujubu et al., 1991) that is undetectable in most normal tissues, becoming abundant in active macrophages and other cells at sites of inflammation (Lee et al., 1992) , and is primarily associated with the nuclear envelope (Lim et al., 1997) . COX-2 is induced in a variety of cell types by diverse stimuli including cytokines, growth factors, mitogens and tumour promoters (Kujubu et al., 1991; Lee et al., 1992) in response to cell activation processes, such as growth, differentiation and inflammation (Ristimaki et al., 1994) . Chandrasekharan et al. (2002) showed that COX-3 shares all of the catalytic features and important structural features of COX-1 and COX-2, but with significantly diminished activity.
Implantation requires the tight regulation of PG production. It has been shown that the concentrations of PGs in the human decidua in early pregnancy are lower than those in the endometrium at any stage of the menstrual cycle (Maathuis and Kelly, 1978; Abel et al., 1980) , and the administration of exogenous PGs induces early pregnancy loss (miscarriage) in all species (Abel et al., 1980; Jaschevatzky et al., 1983) .
COX-1 and COX-2 are involved in the production of the cyclic endoperoxides PGG 2 and PGH 2 , which give rise to PGI 2 , thromboxane A 2 (TXA 2 ), PGE 2 , PGF 2a and PGD 2 . COX2-derived PGs influence uterine angiogenesis during decidualization by differentially regulating VEGF and angiopoietin signalling cascades (Matsumoto et al., 2002) . Studies examining the timing of COX-1 and COX-2 expression with respect to implantation have demonstrated the expression of the COX-1 gene in the uterine epithelium at the time of generalized oedema, whereas expression of the COX-2 was limited to the luminal epithelial cells exclusively surrounding the blastocyst at the time of the attachment reaction (Chakraborty et al., 1996) .
COX-1 is expressed in murine uterine epithelial cells in the morning of D4 of pregnancy, but the expression becomes undetectable by the time of the attachment reaction (Chakraborty et al., 1996) . Interestingly, and in contrast to the knowledge that exogenous PGs induce abortion, COX-2 is expressed in the luminal epithelium and underlying stromal cells, solely at the sites of the blastocyst attachment reaction, and only in the presence of an active blastocyst, suggesting that the blastocyst produces a soluble and localized factor important for implantation success (Lim et al., 1997; Marions and Danielsson, 1999) . It has been shown that COX-1 (2/2) females preserve their fertility, whereas the absence of COX-2 results in infertility (Lim et al., 1997) .
The endometrial production of COX-1 decreases in response to rising progesterone and estradiol levels in the mid-luteal phase of the menstrual cycle, whereas the endometrial content of COX-2 is unaffected by steroid hormones (Marions and Danielsson, 1999) . However, mifepristone decreases the expression of both COX-1 and COX-2 in the endometrium, suggesting that both genes are regulated by progesterone (Marions and Danielsson, 1999) .
Thus, as a result of studies into the role of COX genes in implantation, it is believed that PGs generated by COX-1 are involved in decidualization, whereas PGs generated by COX-2 are involved in angiogenesis for the establishment of the placenta, and are regulated by the implanting blastocyst (Chakraborty et al., 1996; Marions and Danielsson, 1999; Matsumoto et al., 2002) .
HOXA-10 and HOXA-11
Two other components identified as imperative for successful implantation are the homeobox genes HOXA10 and HOXA11. Hox genes (HOX in humans) have a similar 183 base pair sequence, termed the homeobox (McGinnis et al., 1984) . The Hox genes are shared by all animals and are involved in body axis patterning (Eun Kwon and Taylor, 2004) . The mouse and human express a very similar pattern of Hox genes, with a total of 39 HOX genes arranged in four parallel clusters A, B, C and D. With regard to the reproductive tract, HOXA9 to HOXA13 play a critical role in the paramesonephric duct developing into the oviduct, uterus, cervix and upper part of the vagina, respectively (Eun Kwon and Taylor, 2004) .
While most tissues only express Hox genes during the embryonic period, the reproductive tract in women re-establishes Hox gene expression following puberty where this may underlie the plasticity of the endometrium, facilitating the menstrual cycle and pregnancy (McGinnis et al., 1984) .
HOXA10 and HOXA11 are considered to be essential for implantation, and disruption in either results in 'uterine factor' infertility in mice (Eun Kwon and Taylor, 2004) . Although such mice ovulate normally and produce viable preimplantation embryos, they are not able to support implantation. Furthermore, embryos from HOXA10 (2/2) mice successfully implant in pseudo-pregnant wild mice, whereas wildtype embryos do not implant in HOXA-10-or HOXA-11-deficient uteri. In addition, targeted disruption of HOXA11 also results in reduced LIF secretion.
HOXA10 expression is up-regulated by the presence of either estrogen or progesterone and significantly up-regulated in the presence of both estrogen and progesterone simultaneously. At the time of implantation, levels of HOXA10 and HOXA11 both rise dramatically. It has also been demonstrated that in ectopic pregnancies, HOXA10 expression is increased at the site of implantation in the oviduct, with the level of expression almost mirroring the levels found in the endometrium with normal intrauterine pregnancies (Salih and Taylor, 2004) , further supporting the notion that successful implantation is a result of a complex interplay between many different components. Sarno et al. (2009) demonstrated a decreased expression of HOXA10 and HOXA11 in women experiencing a spontaneous miscarriage when compared with patients undergoing a surgical termination of a healthy pregnancy, showing that these two molecules are possibly as important in human pregnancy as they are in mouse pregnancy.
It has also been suggested that blastocysts express an as yet unidentified soluble factor that causes an up-regulation of HOXA10 expression. This further supports the theory that the embryo may be responsible for increasing the receptivity of the adjacent endometrium with the ultimate aim of improving its chances of successful implantation (Eun Kwon and Taylor, 2004) .
As already discussed, LIF, HOXA-10 and COX-2 are all essential for implantation and/or decidualization. It has, however, been noted that while COX-2 expression is abnormal in LIF(2/2) mice, uterine LIF expression is normal in COX-2(2/2) mice. Similarly, COX-2 expression is also reduced in HOXA-10(2/2) mice. However, HOXA-10 expression is normal in LIF(2/2) mice, and LIF expression is normal in HOXA-10(2/2) mice. From this information, Song et al. (2000) concluded that information from the LIF and HOXA-10 signalling pathways might converge on the COX-2 pathway to control implantation, further supporting the notion that implantation is the consequence of a complex interaction of many factors, including a specific cross-talk between the blastocyst and the uterine endometrium.
Endocannabinoids
More recently, endocannabinoids have been identified as playing an important role in successful implantation (Habayeb et al., 2002; Taylor et al., 2007; Sun and Dey, 2008; Maccarrone, 2009; Bambang et al., 2010) . Endocannabinoids are unsaturated fatty acid derivatives of arachidonic acid that act as endogenous ligands for cannabinoid receptors that also bind exocannabinoids/phytocannabinoids from the Cannabis sativa plant.
Derivatives of the C. sativa plant are some of the most widely consumed recreational drugs and exposure to these has been associated with adverse pregnancy outcomes, such as miscarriage and prematurity (Park et al., 2004) . D
9
-tetrahydocannabinol (D 9 -THC), for example, the main psychoactive component in marijuana, inhibits ovulation by suppressing FSH and the pre-ovulation FSH surge in rats (Ayalon et al., 1977) , possibly through the hypothalamic inhibition of GnRH secretion. Mice treated with D 9 -THC demonstrate several defects in embryo development and implantation, such as oviductal retention, asynchronous development and signs of apoptosis in embryos and implantation failure (Paria et al., 2001) .
Following the identification of a receptor that binds to exogenous cannabinoids, such as D 9 -THC, the identity of an endogenous ligand was sought. Arachidonylethanolamide (also known as AEA) was discovered in the 1990s (Devane et al., 1992) , followed quickly by the discovery of another endocannabinoid, 2-arachidonoylglycerol (2-AG). AEA and 2-AG are the most studied cannabinoid receptor agonists. Although both are derivatives of arachidonic acid, 2-AG possesses an ester while AEA is an N-acylethanolamine (NAE). Other members of the NAE family have been identified, including N-palmitoylethanolamine (PEA), N-oleoylethanolamine (OEA) and N-stearoylethanolamine (SEA) (Wang and Ueda, 2009 ).
Murine studies have shown that AEA and its interaction with the cannabinoid receptor CB1 plays an important role in embryo implantation (Yang et al., 1996; Paria et al., 1998; Paria and Dey, 2000) . While 2-AG is also known to interact with the cannabinoid receptors, its exact role is still under investigation (Battista et al., 2012) . It is believed that PEA has both anti-inflammatory activity (Lambert et al., 2002) and is involved in pain sensation (Calignano et al., 1998) , OEA has an anorexic effect (Rodriguez de Fonseca et al., 2001 ) and SEA has pro-apoptotic activity (Maccarrone et al., 2002a, b; Dalle Carbonare et al., 2008) . However, these actions do not appear to be mediated solely via cannabinoid receptors (Ezzili et al., 2010) . Although both PEA and OEA have been linked to either reproductive failure or success in mice and women, the effect is thought to occur through a so-called 'entourage effect', where they act as substrates for the natural catabolic enzyme for AEA, thereby potentiating AEA activity (Bambang et al., 2010) .
Cannabinoid receptors
There are currently two well-documented cannabinoid receptors. The first, CB1, was first described and characterized in the rat brain (Devane et al., 1988) . It has since been shown that human CB1 shares 97.3% sequence identity with rat CB1, and 100% identity within the transmembrane regions (Gérard et al., 1991) . The second cannabinoid receptor, CB2, was first identified in splenic cells and was shown to share 48% identity with CB1 (with 68% identity within the transmembrane regions) (Munro et al., 1993; Habayeb et al., 2002) .
Both CB1 and CB2 are now known to be expressed in a multitude of tissues, but for the purpose of this review, their expression in the reproductive tract will be discussed. Murine studies have shown that CB1 alone is expressed in the oviduct and uterus, whereas both CB1 and CB2 are expressed in preimplantation embryos. CB1 mRNA is primarily detected from the 4-cell stage through to the blastocyst stage, whereas CB2 is present from the 1-cell through to the blastocyst stage Paria et al., 1995; Wang et al., 2004) .
Both CB1 and CB2 are G-protein-coupled receptors with seven transmembrane domains, and belong to the Gi/o family (Wang et al., 2003; Sun and Dey, 2008; Wang and Ueda, 2009 ). Binding of endocannabinoids to either of these receptors can trigger a whole host of signalling cascades, including regulation of Ca 2+ channels, stimulation of mitogenactivated protein kinase and activation of cytosolic phospholipase A2 (Wang et al., 2003; Sun and Dey, 2008; Wang and Ueda, 2009) . They also have some opposing actions, for example, CB1 causes activation of inducible nitric oxide synthase, whereas CB2 causes inhibition of the same pathway (Sordelli et al., 2011) . The signalling cascades triggered by binding to CB1 and CB2 all have an impact on implantation.
There is also emerging evidence of a possible third endocannabinoid receptor, known as CB3 or GPR55 (McPartland et al., 2006) . CB3 has been shown to bind endocannabinoids at an extracellular site (as do CB1 and CB2) but shares low sequence homology (10 -15%) with the classical CB1 and CB2 (Maccarrone, 2009) . Agonist binding to CB3 triggers activation of the small GTPase proteins phoA, rac and cdc44 which, once activated, interact with adenylyl cyclase and thus join the G-protein signalling cascade (Ross, 2009) . With regard to early pregnancy events, CB3 has linked to the rat decidual remodelling process necessary for placental development (Fonseca et al., 2011) .
A 'non-cannabinoid' receptor for AEA has also been identified (Van Der Stelt and Di Marzo, 2004; Di Marzo and De Petrocelli, 2010) , called the transient receptor potential vanilloid 1 (TRPV1), which is a ligand gated, six-transmembrane-spanning protein that is activated by molecules derived from plants, such as capsaicin (the pungent component of 'hot' red peppers). While TRPV1 has been shown to affect sperm function (Francavilla et al., 2009 ) and has been identified in the uterus (Liu et al., 2012) , its precise effects on reproduction have not yet been established.
Synthesis
Endocannabinoids were considered to be generated 'on demand' from long-chain polyunsaturated fatty acid precursors and to act in both an autocrine and a paracrine fashion (Guo et al., 2005) , as well as following release into the lymphatic system/bloodstream (Taylor et al., 2007) . However, recent evidence suggests that they are stored and transported around the cell by fatty acid binding proteins (Kaczocha et al., 2009) .
N-acylphopatidylethanolamines (NAPEs) are thought to be the precursors for NAEs. When considering the synthesis of AEA, the main enzyme involved in this process is NAPE-PLD, a type-D phospholipase (PLD), which hydrolyses NAPE to AEA (Guo et al., 2005) . However, NAPE-PLD knockout mice have been shown to have wild-type levels of AEA in their brains, with only a moderate decrease in levels of OEA and PEA, highlighting the possibility of additional pathways responsible for NAE (especially AEA) synthesis. These pathways were later identified; the first involves the serine hydrolase ABHD4, and the second involves the phosphatase, protein tyrosine phosphatase PTPN22 (Simon and Cravatt, 2006; Muccioli, 2010) . These pathways are shown in Fig. 2 .
Degradation
AEA is catabolized into ethanolamine and arachidonic acid (the precursor for PG synthesis). The first enzyme identified as being involved in the degradation of AEA was Fatty Acid Amide Hydrolase (FAAH) and Maccarrone et al. (2001) have shown that human lymphocyte FAAH is stimulated by progesterone and Th2 cytokines. Most studies investigating this enzyme have been conducted in mice, with murine FAAH sharing 80% sequence identify with human FAAH (Giang and Cravatt, 1997) .
A gene that encodes a second FAAH ('FAAH-2') enzyme has been found in multiple primate genomes, marsupials and more distantly related vertebrates but interestingly has not been identified in the mouse or rat genome (Wei et al., 2006) . The original FAAH (FAAH-1) and FAAH-2 share 20% sequence identity across their entire primary structure (Wei et al., 2006) . Unlike FAAH-1, FAAH-2 is localized in cytosolic lipid droplets, and is less efficient at hydrolysing NAEs. It has been found to have a high expression in peripheral tissues and because of this, it has been suggested that FAAH-2 might have a 'rescue role' in hydrolysing NAEs upon FAAH-1 inactivation (Muccioli, 2010) .
Following the demonstration that blastocyst culture medium does not have the ability to hydrolyse AEA, it has been proposed that a 'FAAH activator' is required rather than the blastocyst directly express FAAH. The exact nature of this FAAH activator is still unknown; its activity is fully neutralized by lipases (whereas phospholipases A 2 , C or D, DNAse or RNAse have no effect), and for this reason, it is suspected to be a lipid. However, it is not thought to be any of the lipids know to be released by blastocysts, such as platelet-activating factor, leukotriene B 4 or PGs E 2 and F 2 (Maccarrone et al., 2004) .
Effects on implantation
Murine studies have shown that a careful balance in the activities of NAPE-PLD and FAAH is required to ensure that appropriate levels of AEA are available during implantation N-acylphosphatidylethanolamine-specific phospholipase D Guo et al., 2005) . This 'anandamide tone' is crucial for successful implantation to occur (Wang et al., 1999) . In 1997, Schmid et al. (1997) demonstrated that a high AEA levels inhibit the development of 2-cell embryos into blastocysts and the zona-hatching of blastocysts that develop from 8-cell embryos in vitro. Blastocysts exposed to low levels of AEA in culture also exhibit accelerated trophoblast differentiation and outgrowth, whereas at higher doses of AEA, inhibition of trophoblast differentiation is observed (Wang et al., 2006a, b) .
The work of Sun et al. (2010) further supports this notion of 'anandamide tone' being important because they demonstrated that both CB12/2 and FAAH 2/2 mice had a significant reduction in litter size, suggesting that both high and low levels of AEA have a negative effect on pregnancy. Furthermore, Guo et al. (2005) demonstrated that the uterine epithelium is a major source of AEA prior to implantation and showed that NAPE-PLD activity correlates with AEA levels, whereas higher expression of NAPE-PLD was noted in a 'non-receptive' uterus when compared with a uterus that was 'receptive' to implantation. Interestingly, they showed that NAPE-PLD expression was significantly lower at the implantation site when compared with the peri-implantation site, and proposed that the embryo might play a role in regulating these levels. Wang et al. (2006a, b) demonstrated in mice that the preimplantation blastocyst expresses NAPE-PLD at all stages of development, and this is found in both the cytoplasm and nucleus of the preimplantation embryo, whereas FAAH protein is only expressed in embryos beyond the 2-cell Figure 2 Proposed pathways of synthesis of NAEs, with NAPE-PLD thought to be the main route. A schematic representation of the various proposed routes of NAE synthesis is shown. Red box, precursors; blue box, intermediate compounds; green box, the final product; white box, enzymes involved in the synthesis. Thicker arrows indicate the dominant pathway to NAE synthesis in most cells. NAPE, N-acyl phosphatidylethanolamine; pNAPE, N-acylethanolamine plasmalogen; Lyso-NAPE, 1-alkenyl-2-hydroxy-glycero-3-phospho (N-acyl) ethanolamines; Abh4, alpha/beta-hydrolase 4; GDE1, glycerophosphadiesterase; NAPE-PLD, N-acylphosphatidylethanolamine-specific phospholipase D.
Mechanisms of implantation stage and limited to the outer cells of the morula and trophoectoderm (Table III) . They surmised that the increasing levels and localized expression of FAAH in morulae and blastocysts suggest that FAAH-mediated AEA degradation functions as a protective mechanism against the negative effects that high levels of AEA have on implantation. A recent study by El-Talatini et al. (2009) in women revealed similar reductions in plasma AEA levels from oocyte retrieval (OR) to ET in IVF/ICSI patients. Their findings support the above conclusion, and showed that patients who successfully became pregnant had a significant fall in their plasma AEA levels between OR to ET, whereas the non-pregnant group did not show that drop.
It is not only the absolute levels of AEA that affect the success of implantation, but also the presence or absence of receptors. Wang et al. (2006a, b) demonstrated that the absence of the CB1 receptor in embryos results in asynchronous development, while the absence of maternal CB1 receptors results in oviductal retention in the embryo. Conversely, wild-type mice subjected to high levels of methanandamide (a stable AEA analogue) or natural THC showed pregnancy loss, with the embryos also retained in the oviduct. Guo et al. (2005) demonstrated that on Days 1-4 of mouse pregnancy, NAPE-PLD is primarily expressed in the luminal and glandular epithelium of the uterus (when compared with the stroma), indicating that the epithelium is the major source of uterine AEA prior to implantation. However, on Days 5-7 of pregnancy, expression of NAPE-PLD is primarily restricted to the luminal and glandular epithelium of the interimplantation region, with very low expression in the luminal epithelium close to the implanting blastocyst. With this result, they suggested that there is a potential role for the implanting embryo in regulating uterine NAPE-PLD expression and AEA levels.
The ovarian sex steroids, estradiol and progesterone, both influence the endocannabinoid system. Progesterone has been shown to stimulate the activity of FAAH in humans and it has been found that ovariectomized animals have significantly reduced levels of FAAH when compared with Paria et al. (1996) , Schmid et al. (1997) and Wang et al. (2006a Wang et al. ( , b, 1999 . NAPE-PLD, N-acylphosphatidylethanolamine-specific phospholipase D; AEA, anandamide; FAAH, fatty acid amide hydrolase.
controls (Maccarrone et al., 2001; Battista et al., 2008) . Conversely, high levels of estrogen and/or progesterone down-regulate the expression of NAPE-PLD (Guo et al., 2005) . In addition, El-Talatini et al. (2010) suggested that during the follicular phase of the menstrual cycle, FSH might be the main controlling factor regulating plasma AEA levels, whereas during ovulation, LH and estrogen may regulate implantation and early pregnancy AEA levels. It is known that peripheral lymphocytes play a critical role in human embryo implantation. The addition of AEA to human lymphocytes in vitro inhibits the release of LIF, further highlighting the close interaction between the many components involved in supporting early pregnancy. FAAH is also thought to be a key player in the lymphocyte-mediated control of the hormone-cytokine network at the fetal -maternal interface. Maccarrone et al. (2001) demonstrated that lymphocyte FAAH activity was significantly lower in patients who failed to become pregnant than in those who became pregnant. At the same time, they did not demonstrate a significant difference in the activity of the AEA membrane transporter between the two groups. They also added further evidence for the hypothesis that high levels of AEA were associated with a failure to achieve an ongoing pregnancy after ET (these considerations are highlighted in Table IV ).
In the context of this review, it is noteworthy that female mice and women both express a full complement of the endocannabinoid system components.
In summary, the endocannabinoid system is now considered to be critical for successful pregnancy in mice, and appears to play an important role in human pregnancies, even though the precise mechanism(s) remain obscure. While the importance of AEA is slowly becoming understood, the involvement of 2-AG, OEA and PEA remains unclear.
The future of studies into implantation?
The purpose of this review was to highlight the similarities and differences between human and murine models in the process of implantation and to focus on the key components of successful implantation. Unfortunately, it has also highlighted that there are still many unanswered questions when it comes to 'Why do some embryos implant, and others do not?'. When looking from a clinical perspective, we are still some way from answering the question, 'What can be done to improve implantation rates?'. The reasons for this are manifold, but could be due to the following reasons.
First, there are still gaps in our knowledge about exactly which ligands are involved. This review has only discussed the key ligands involved in implantation, and even focusing on these has identified gaps in our understanding, for example, while it is already know that COX-1 plays a role in decidualization, and COX-3 shares many features of COX-1, there are few data on involvement of COX-3 in implantation.
In addition, a large proportion of data are from animal models. This review has highlighted reasons why this cannot always be translated into human implantation. For example, Schmid et al. (1997) demonstrated the highest concentration of AEA found in any species to date in the non-implantation site of the pregnant mouse uterus. Following this discovery, many studies have examined AEA's effect on implantation and pregnancy success in murine pregnancies. However, with increasing evidence highlighting the differences between humans and mice, it might now be time to focus more on the effect of AEA on implantation and pregnancy success in human pregnancies.
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